a Department of Surgery, Severance Hospital , Yonsei University College of Medicine , Seoul , South Korea.
Expert Rev Anticancer Ther. 2018 Apr;18(4):351-358. doi: 10.1080/14737140.2018.1442217. Epub 2018 Feb 19.
Colorectal cancer is one of the most common malignancies in the world, and it exhibits differences in incidence, pathogenesis, molecular pathways, and outcome depending on the location of the tumor. Differences in the microbiome, clinical characteristics, and chromosomal and molecular characteristics have been reported between the right and left side of the colon. Areas covered: This review focuses on the latest developments in epidemiological and chromosomal and molecular studies, which have enhanced our understanding on the underlying genetic and immunological differences between the right-sided colon and the left-sided colorectum in metastatic colorectal cancer. Expert commentary: The numerous findings regarding differences between right- and left-sided colon cancers should have an impact on colorectal cancer screening and therapy. The location of the colorectal cancer should be considered before group stratification into genetic, clinical, and especially chemotherapy trials. A more tailored approach to colon cancer treatment would be highly desirable if future trials further support the hypothesis of two distinct tumor entities.
结直肠癌是世界上最常见的恶性肿瘤之一,其发病率、发病机制、分子途径和预后因肿瘤位置而异。据报道,结直肠的左右两侧在微生物组、临床特征以及染色体和分子特征方面存在差异。
本综述重点介绍了在流行病学以及染色体和分子研究方面的最新进展,这些研究增强了我们对转移性结直肠癌中右侧结肠和左侧结直肠之间潜在遗传和免疫差异的理解。
关于右半结肠癌和左半结肠癌之间差异的众多发现应该会对结直肠癌的筛查和治疗产生影响。在进行遗传、临床,特别是化疗试验的分组之前,应考虑结直肠癌的位置。如果未来的试验进一步支持两种不同肿瘤实体的假设,那么对结肠癌治疗采用更具针对性的方法将是非常可取的。